Skip to main content
Videos

Driving Change: What the PCC Working Group Has Learned and What’s Next

The Predictable Cost of Care Working Group (the PCC) is a multi-organizational effort comprised of pharmaceutical and biotech manufacturers, pathway vendor organizations, community practices, IDNs, and payers. The purpose of the PCC is to inform pathway developers and practices about a greater span of costs than simply drug costs; provide relevant context in competitive situations; and identify areas for quality improvement, efficiency. In this discussion, Rhonda Henschel, SVP at US Oncology, shares how treatment pathways and the Predictable Cost of Care model support value-based care by enabling scalable, disease-agnostic cost frameworks and informing pathway development through consistent, data-driven decision-making.

© 2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Journal of Clinical Pathways or HMP Global, their employees, and affiliates.